0001567619-21-001127.txt : 20210119 0001567619-21-001127.hdr.sgml : 20210119 20210115185213 ACCESSION NUMBER: 0001567619-21-001127 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210119 DATE AS OF CHANGE: 20210115 EFFECTIVENESS DATE: 20210119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RenBio, Inc. CENTRAL INDEX KEY: 0001840723 IRS NUMBER: 465353064 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-386614 FILM NUMBER: 21533368 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 600 CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: (646) 440-9411 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 600 CITY: NEW YORK STATE: NY ZIP: 10016 D 1 primary_doc.xml X0708 D LIVE 0001840723 RenBio, Inc. 430 EAST 29TH STREET SUITE 600 NEW YORK NY NEW YORK 10016 (646) 440-9411 DELAWARE None None Corporation true 2020 Neal Padte 430 East 29th Street Suite 600 New York NY NEW YORK 10016 Executive Officer Director Chi-Chuan Chen 430 East 29th Street Suite 600 New York NY NEW YORK 10016 Director David Chu 430 East 29th Street Suite 600 New York NY NEW YORK 10016 Director Tamon Tseng 430 East 29th Street Suite 600 New York NY NEW YORK 10016 Director Wan Feng Ting 430 East 29th Street Suite 600 New York NY NEW YORK 10016 Director Biotechnology Decline to Disclose 06b false 2020-12-30 false true false 0 24000000 14000000 10000000 false 7 0 0 0 false RenBio, Inc. /s/ Neal Padte Neal Padte Chief Operating Officer 2021-01-07